Location History:
- San Jose, CA (US) (2014)
- Rye, NY (US) (2018)
Company Filing History:
2 out of 5,309 
1 out of 2,119 
Years Active: 2014-2018
Title: The Innovative Contributions of Joel T Dudley
Introduction
Joel T Dudley is a prominent inventor based in San Jose, CA. He has made significant contributions to the field of biomedical research, particularly in the area of glucocorticoid receptor activity and its implications for therapeutic treatments. With a total of 3 patents, Dudley's work has the potential to impact various medical conditions.
Latest Patents
One of Dudley's latest patents is titled "Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists." This patent discloses methods and pharmaceutical compositions for treating diseases associated with glucocorticoid receptor expression and activity. The methods involve administering a glucocorticoid receptor agonist alongside a REDD1 inhibitor, which can be given before, concurrently, or after the GR agonist.
Another notable patent is "Method and system for the use of biomarkers for regulatory dysfunction in disease." This invention provides an improved marker for diseases by measuring the binding of transcription factors. These markers can be utilized in diagnostics and to adjust disease risk profiles for healthy individuals based on typical genetic variants.
Career Highlights
Dudley has worked at prestigious institutions such as Leland Stanford Junior University and Northwestern University. His research has focused on the intersection of genetics and disease, contributing to a deeper understanding of how certain factors influence health outcomes.
Collaborations
Throughout his career, Dudley has collaborated with notable colleagues, including Atul J Butte and Alexander A Morgan. These partnerships have furthered his research and expanded the impact of his inventions.
Conclusion
Joel T Dudley is a distinguished inventor whose work in the biomedical field has led to significant advancements in understanding glucocorticoid receptor activity. His patents reflect a commitment to improving therapeutic approaches for various diseases.